Open-label study of Equetro [carbamazepine ER] for the treatment of mania in children ages 6-12 with bipolar I, bipolar II, and bipolar spectrum disorder.
Phase of Trial: Phase IV
Latest Information Update: 21 Jun 2010
At a glance
- Drugs Carbamazepine (Primary)
- Indications Bipolar disorders
- Focus Therapeutic Use
- 09 Feb 2009 Actual number of patients (33) added as reported by ClinicalTrials.gov.
- 10 Jun 2008 Status change from recruiting to completed, according to clinicaltrials.gov.
- 17 Nov 2005 New trial record.